Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GlucoRx is a UK-based diabetes care and medical device company focused on glucose monitoring and broader diabetes management solutions. The company markets blood glucose meters, continuous glucose monitoring systems, ketone and multiparameter meters, insulin pen needles, lancets, diabetic foot care products, glucose gels, and related digital health tools. Its business is centered on commercial-stage products rather than a therapeutic drug pipeline, with a strong emphasis on affordability, integrated technology, and support for patients, clinicians, pharmacies, and the NHS. GlucoRx also highlights AI-enabled data management and international expansion through distributors and local operations. The company appears to be an active private healthcare company rather than a biotech or pharmaceutical drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GlucoRx.